The Effect of Octreotide on Parathyroid Carcinoma [2]

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 2, 2004, Pages 1016-

  Denney, Amanda M ^a   Watts, Nelson B ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; OCTREOTIDE; PARATHYROID HORMONE;

BONE METASTASIS; CLINICAL EXAMINATION; CLINICAL FEATURE; DIARRHEA; DIZZINESS; DOSE RESPONSE; DRUG EFFECT; HEADACHE; HUMAN; HYPERCALCEMIA; LABORATORY TEST; LETTER; NAUSEA; NONHUMAN; PARATHYROID CARCINOMA; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; SIDE EFFECT; TREATMENT INDICATION;

ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA; HUMANS; OCTREOTIDE; PARATHYROID NEOPLASMS;

EID: 10744229442     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031825     Document Type: Letter

References (7)

1. Shane E 2001 Parathyroid carcinoma. J Clin Endocrinol Metab 86:485-493
2. Koyano H, Shishiba Y, Shimizu T, Suzuki N, Nakazawa H, Tachibana S, Murata H, Furui S 1994 Successful treatment by surgical removal of bone metastasis producing PTH: new approach to the management of metastatic parathyroid carcinoma. Intern Med 33:697-702
3. Miller D, Edmonds MW 1991 Hypercalcemia due to hyperparathyroidism treated with a somatostatin analogue. Can Med Assoc J 145:227-228
4. Lucarotti ME, Hamilton JA, Farndon JR 1994 Somatostatin and primary hyperparathyroidism. Br J Surg 81:1141-1143
5. Zielke A, Hasse C, Bruns C, Sitter H, Rothmund M 1997 Octreotide: effective treatment for hyperparathyroidism? A prospective, randomized, controlled clinical trial. Surgery 121:606-610
6. Macdonald JS 1991 Parathyroid neoplasia. Curr Opin Oncol 3:139-141
7. Ridefelt P, Rydinge J, Akerstrom G, Hellman P, Rastad J 1995 Somatostatin and octreotide interfere with calcium signalling in pancreatic B-cells but not in normal and pathological parathyroid cells. Horm Metab Res 28:588-591